附註:Includes bibliographical references.
""IMMUNIZATION SAFETY REVIEW""; ""Copyright""; ""Acknowledgments""; ""Contents""; ""Executive Summary""; ""PLAUSIBILITY ASSESSMENT""; ""Biological Plausibility""; ""Causality""; ""SIGNIFICANCE ASSESSMENT""; ""PUBLIC HEALTH RESPONSE""; ""Policy Review and Analysis""; ""Public Health and Biomedical Research""; ""Epidemiological Research""; ""Clinical Research""; ""Basic Science Research""; ""Communications""; ""SUMMARY""; ""REFERENCES""; ""Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders ""; ""ORIGINS OF THE IMMUNIZATION SAFETY REVIEW PROJECT""
""THE CHARGE TO THE COMMITTEE""""THE STUDY PROCESS""; ""THE FRAMEWORK FOR ASSESSING CAUSALITY""; ""UNDER REVIEW: THIMEROSAL-CONTAINING VACCINES AND NEURODEVELOPMENTAL DISORDERS""; ""Thimerosal in Vaccines""; ""Neurodevelopmental Disorders""; ""Autism""; ""Attention Deficit/Hyperactivity Disorder (ADHD)""; ""Speech or Language Delay""; ""PLAUSIBILITY ASSESSMENT""; ""Evidence Regarding Association: Biological Plausibility""; ""Mercury Toxicokinetics""; ""Comparisons of Ethylmercury and Methylmercury""; ""Health Effects of High-Dose Exposures to Thimerosal, Ethylmercury, and Methylmercury""
""Health Effects of Low-Dose Exposures to Thimerosal and Methylmercury""""Investigations Related to Mercury and Heavy Metals in Children with Autism""; ""Application of Methylmercury Exposure Guidelines to Thimerosal Exposure from Vaccines""; ""Biological Plausibility Argument""; ""Evidence Regarding Association: Case Reports, Case Series, and Uncontrolled and Controlled Epidemiological Studies""; ""Case Reports and Case Series""; ""Epidemiological Studies""; ""CAUSALITY ARGUMENT""; ""SIGNIFICANCE ASSESSMENT""; ""Concern Regarding Neurodevelopmental Disorders""
""Continued Exposure to Thimerosal""""Use of Thimerosal-Containing Vaccines in Other Countries""; ""Confusion from Changes in Hepatitis B Immunization Policy""; ""Trust in the Safety of Vaccines""; ""Conclusion""; ""RECOMMENDATIONS REGARDING THE PUBLIC HEALTH RESPONSE""; ""Policy Review and Analysis""; ""Public Health and Biomedical Research""; ""Epidemiological Studies""; ""Clinical Studies""; ""Basic Science Studies""; ""Communications""; ""SUMMARY""; ""REFERENCES""; ""Appendix A Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism Executive Summary ""
""OVERVIEW OF THE IMMUNIZATION SAFETY REVIEW PROJECT""""THE HYPOTHESIZED RELATIONSHIP BETWEEN MMR AND AUTISM""; ""PLAUSIBILITY ASSESSMENT""; ""SIGNIFICANCE ASSESSMENT""; ""RECOMMENDATIONS""; ""Public Health Response""; ""Policy Review""; ""Research Regarding MMR and ASD""; ""Communications""; ""General and Crosscutting Issues""; ""SUMMARY""; ""REFERENCES""; ""Appendix B Monday, July 16, 2001 Meeting Agenda ""; ""Appendix C Thimerosal Content in Licensed Vaccines ""; ""Appendix D Immunization Safety Review Committee Biosketches ""; ""Board on Health Promotion Disease Prevention Liaison""
